Pharmaceutical Executive Digest:
Having trouble viewing this e-mail? Click here.

 
You are subscribed to %%list.name%% as %%emailaddr%%.
Click here to unsubscribe or edit your member profile.
Pharmaceutical Executive Europe E-News
 
 
 
 
 
 

You can now follow us on Twitter at Twitter.com/pharmexecdigi
 
Survey
We asked 40 pharma leaders, which is your preferred social media tool for professional use?

Twitter 7%
LinkedIn 80%
Facebook 10%
Other 3%

Talk to us:
editor@pharmexeceurope.com

Advertise with us: jgray@advanstar.com

7 February, 2012
In this Issue
CROs 2012
Jim Miller points to some recent private-equity buyouts of CROs that show both the upside and downside for potential investors. More...
The Patient Opinion Leaders
Elys Roberts and Sarah Phillips profile the rise of the Pro-Patients, a new breed of informed, articulate and determined advocates for consumer rights, and look at how pharma might work with them. More...
HBA Woman of the Year 2012
This year's recipient of the Healthcare Businesswomen's Association (HBA) Woman of the Year award represents something of a departure from the norm, given that most recent awardees have come from the Big Pharma "C suite" of senior managers with line responsibilities... More...
India to Double Pharma Exports by 2014
With the $12-billion valued Indian pharmaceutical industry expected to grow at an compound annual growth rate (CAGR) of 16%, the Indian government plans to capitalize on the growth potential in an effort to beat the competition from its Asian counterparts in the generic-drug and API manufacturing market. More...
Also in this issue…
Emerging Markets: Crossing the Cancer Divide
Latest International Pharma Appointments
Upcoming Global Events
Event Profile
Pharma Regulatory Policy Exchange
May 7-8, 2012
Washington, D.C.
USA
Prepare for a new wave of legislative and regulatory policies that will shape the life sciences industry for years to come. Learn best practices on how the shifting regulatory and policy landscape will affect the biopharma industry going forward with Bayer HealthCare Pharmaceuticals, Bristol Myers Squibb, Eisai, Eli Lilly and Company, EMD Serono, Merck, Novartis and Shire Pharmaceuticals!
Register by March 10th at http://www.cbinet.com/policyexchange and save $300 with priority code: QSS925.

 
You are subscribed to %%list.name%% as %%emailaddr%%. Click here to unsubscribe or edit your member profile.

To ensure delivery to your inbox, please add us to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone
numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other
opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact
information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.com or by mail
at Advanstar Communications Inc., Bridgegate Pavilion, 4A Chester Business Park, Wrexham Road, Chester, CH4 9QH, UK